Saturday, October 25, 2014

What happens when physicians refuse pharmaceutical samples?

This family medicine clinic in rural Oregon found that after instituting a policy of not accepting pharmaceutical detail rep samples, that:

a) clinic operations were enhanced after eliminating interruptions from pharmaceutical representatives

b) there was a positive response from the public, and

c) there were reduced diversion of samples for personal use.

Clinicians interviewed agreed that

a) brand pharmaceutical samples were of questionable benefit

b) information obtained from industry reps was incomplete or of questionable objectivity, and

c) that it was helpful to substitute other educational activities to replace former industry

One practice's experiment in refusing detail rep... [J Fam Pract. 2011] - PubMed - NCBI